- Home
- ABSI vs GUG Comparison
ABSI vs GUG Comparison
Compare ABSI & GUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- GUG
- Stock Information
- Founded
- ABSI 2011
- GUG 2021
- Country
- ABSI United States
- GUG United States
- Employees
- ABSI N/A
- GUG N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- GUG Trusts Except Educational Religious and Charitable
- Sector
- ABSI Health Care
- GUG Finance
- Exchange
- ABSI Nasdaq
- GUG Nasdaq
- Market Cap
- ABSI 457.6M
- GUG 493.4M
- IPO Year
- ABSI 2021
- GUG N/A
- Fundamental
- Price
- ABSI $3.01
- GUG $15.08
- Analyst Decision
- ABSI Strong Buy
- GUG
- Analyst Count
- ABSI 6
- GUG 0
- Target Price
- ABSI $8.67
- GUG N/A
- AVG Volume (30 Days)
- ABSI 2.4M
- GUG 108.9K
- Earning Date
- ABSI 11-12-2024
- GUG 01-01-0001
- Dividend Yield
- ABSI N/A
- GUG 9.67%
- EPS Growth
- ABSI N/A
- GUG N/A
- EPS
- ABSI N/A
- GUG N/A
- Revenue
- ABSI $4,207,000.00
- GUG N/A
- Revenue This Year
- ABSI $8.57
- GUG N/A
- Revenue Next Year
- ABSI $169.72
- GUG N/A
- P/E Ratio
- ABSI N/A
- GUG N/A
- Revenue Growth
- ABSI N/A
- GUG N/A
- 52 Week Low
- ABSI $2.45
- GUG $12.71
- 52 Week High
- ABSI $6.72
- GUG $15.06
- Technical
- Relative Strength Index (RSI)
- ABSI 44.56
- GUG 34.28
- Support Level
- ABSI $2.79
- GUG $14.90
- Resistance Level
- ABSI $4.11
- GUG $15.28
- Average True Range (ATR)
- ABSI 0.42
- GUG 0.27
- MACD
- ABSI -0.04
- GUG -0.04
- Stochastic Oscillator
- ABSI 12.28
- GUG 20.22
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.